November 23, 2022The Adderall shortage first reported this summer and confirmed by the U.S. Food and Drug Administration (FDA) in October, is dragging on — and dragging down many patients’ mental health in the process.
A significant population of patients cannot reliably procure the ADHD medication from local pharmacies, and many prescribers are trying to find alternatives to the immediate and extended-release formulations of Adderall for their patients, according to a recent ADDitude survey.
All of this is causing anxiety, treatment disruption, and symptom flare-ups.In September, 80% of ADDitude poll respondents said they were having trouble getting their ADHD medication.
Read more on additudemag.com